THINQ Pharma-CRO Limited – FDA Inspection, Sep 13, 2024

Record Details

This FDA Inspection record concerns THINQ Pharma-CRO Limited, with an inspection on September 13, 2024, issued by the Office of Inspections and Investigations, covering human drugs.

Company: THINQ Pharma-CRO Limited
Inspection Date: September 13, 2024
Product Type: Human Drugs
Office: Office of Inspections and Investigations
People: Karen A. Briggs (FDA Associated Person)
Lillian S. Wu (Issuing Officer)

View Company Profile

ID · 798932df-a2ef-4028-b7ce-b010ee053948

Inspection Facts

Inspection number: 1250734
FDA center: Human Drugs
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore THINQ Pharma-CRO Limited

FDA Inspection

THINQ Pharma-CRO LimitedSeptember 13, 2024

THINQ Pharma-CRO Limited – FDA Inspection, Sep 13, 2024

Record Details

This FDA Inspection record concerns THINQ Pharma-CRO Limited, with an inspection on September 13, 2024, issued by the Office of Inspections and Investigations, covering human drugs.